产品
  • 产品
  • 供应商
  • 采购
  • 资讯
  • 会展
首页 制药产品大全 原料药 激素及调节药原料 特立帕肽原料

特立帕肽原料

2026-02-27
52232-67-4
中国药典,美国药典,欧洲药典
药用级

产品详情

特立帕肽原料
激素类
52232-67-4
中国药典,美国药典,欧洲药典
药用级
特立帕肽,teriparatide,52232-67-4,DB06285
根据需求
50G
50KGS
TT IN ADVANCE
现货
北美洲,中/南美洲,西欧,东欧,大洋洲,亚洲,中东,非洲

产品描述

Teriparatide(重组人甲状旁腺激素)是一种用于治疗骨质疏松症的有效合成代谢剂.

我公司采用严格的制造过程和质量控制措施,以确保激素API的纯度,效能和安全性。这些API通常是使用化学或生物技术方法合成的,通常从天然激素来源或重组DNA技术开始。制定了严格的监管指南,以确保荷尔蒙药物API的功效和安全性,以确保患者接受高质量的药物。

随着对激素相关疗法的需求不断增长,持续的研发工作着重于提高有效性并降低激素剂API的副作用。这包括探索新型输送系统,高级配方和靶向药物输送方法。通过不断提高我们在荷尔蒙药物中的理解和能力,医学界可以改善荷尔蒙病人的患者结果和生活质量。

Teriparatide (recombinant human parathyroid hormone) is a potent anabolic agent for the treatment of osteoporosis.

Our company employs strict manufacturing processes and quality control measures to ensure the purity, efficacy and safety of hormone apis. These apis are typically synthesized using chemical or biotechnological methods, usually starting with natural hormone sources or recombinant DNA techniques. Strict regulatory guidelines are in place to ensure the efficacy and safety of hormone drug apis to ensure that patients receive high-quality drugs.

As the demand for hormone-related therapies continues to grow, ongoing research and development efforts focus on improving effectiveness and reducing the side effects of hormone agent apis. This includes exploring novel delivery systems, advanced formulations and targeted drug delivery methods. By continually improving our understanding and capabilities in hormonal medicine, the medical community can improve patient outcomes and quality of life for hormonal patients.

亿帆医药股份有限公司
访问店铺
注册资本
公司地址
联系人

公司简介

我公司的总公司——亿帆医药股份有限公司,简称:亿帆医药,证券代码:002019。是专注医药健康领域的创新型研发生产企业,致力于以经典发现与经典创新并举,对可能性方案展开科学验证,为全球医药健康事业贡献更新的专业力量。围绕大分子、小分子、合成生物、特色中药四大核心业务,我们在旧金山、上海、北京、杭州、合肥搭建了五大自主科研中心,充分协同海内外优质创新资源,持续加码创新研发,初步形成了符合临床需求并具有商业价值的差异化、多元化、有竞争力的产品研发管线,近50个在研产品,覆盖创新药、生仿药、仿制药、中成药、合成生物等。我公司自主生产的大分子生物原料药及中间体:生长激素、司美格鲁肽、利拉鲁肽、特立帕肽、甘精胰岛素、门冬胰岛素、德谷胰岛素 以及各类工具酶等面向国际市场推广。我公司自主生产的泛酸钙、泛醇、beta-丙酸、泛解酸内酯、3-氨基丙醇等产品,技术、品质和销量均国际领先!我公司也分销代理维生素K1、二氮嗪、缩宫素、重酒石酸去甲肾上腺素、间苯三酚、依克多因、麦角硫因、阿基瑞林等原料药及医美产品。欢迎友好互利、双赢合作!Our company -- Yifan Pharmaceutical Co., LTD., referred to as: Yifan Pharmaceutical, stock code: 002019. Is an innovative R & D and production enterprise focusing on the field of medicine and health, committed to classical discovery and classic innovation, scientific verification of possible solutions, and contribution to the global medical and health industry. Focusing on the four core businesses of macromolecule, small molecule, synthetic biology and specialty Chinese medicine, we have set up five independent scientific research centers in San Francisco, Shanghai, Beijing, Hangzhou and Hefei, fully cooperating with high-quality innovation resources at home and abroad, continuously increasing innovative research and development, and initially formed a differentiated, diversified and competitive product research and development pipeline that meets clinical needs and has commercial value. Nearly 50 products are under research, covering innovative drugs, imitation drugs, generic drugs, proprietary Chinese medicines, synthetic biology and so on.The macromolecular biological APIs and intermediates independently produced by YIFAN: Human growth hormone(Somatropin), HGH,Semaglutide, Liraglutide, Teriparatide, Insulin Glargine, Insulin Aspartate,Insulin Aspart, Insulin Degludec and various Tool Enzymes are marketed to the international market.Our independent production of calcium pantothenate, panthenol, beta-propionic acid, pantothenolactone, 3-amino-propanol and other products, technology, quality and sales are leading in the world!Our company also distributes and agents vitamin K1, diazine, oxytocin, norepinephrine bitartrate, phloroglucinol, ecdoin, ergothioneine, acirirelin and other raw materials and medical products.Welcome friendly, mutually beneficial and win-win cooperation!
业务类型:
成立日期:
年营业额:
主营产品类别: